Gastrointestinal tumor diagnosis and treatment system

Abstract

The invention provides a gastrointestinal tumor diagnosis and treatment system. The system comprises a targeting probe capable of specifically recognizing gastrointestinal tumor; the targeting probe comprises one or any combination of a BRCAA1 antibody, an HAI-178 human-derived antibody, a PLCe1 antibody, a gastrin G-17 antibody and a CD44-V6 antibody which can be adsorbed on the gastrointestinal tumor in a targeting manner, and at least one or any combination of a molecular contrast agent and a light-absorbing and heat-producing functional substance is coupled to the antibody; and a capsule endoscope is provided with a multi-wavelength light source module which at least comprises a white light module and a near-infrared light module, an in-vivo position control module and an in-vitro image receiving module. The probe can specifically recognize and be adsorbed on the gastrointestinal tumor, and targeted imaging detection is realized under the irradiation of a specific light source of the capsule endoscope, so that leak detection is effectively prevented, and the novel specific detection and treatment system is provided for the gastrointestinal tumor.

Description

technical field [0001] The invention relates to the field of medical devices, in particular to a system for diagnosing and treating gastrointestinal tumors. Background technique [0002] Malignant tumors of the gastrointestinal tract, namely gastrointestinal cancer, have extremely high morbidity and mortality, and are one of the major diseases threatening human health. For example, gastric cancer is one of the four major human malignant cancers. In my country, the incidence and mortality of gastric cancer rank second and third among malignant tumors, respectively. The extremely high mortality rate of gastrointestinal cancer can be attributed to its extremely low early detection rate. The five-year incidence rate of early gastric cancer after treatment can reach more than 90%, while that of advanced gastric cancer is less than 24%. However, the detection rate of early gastric cancer in my country is still Less than 15%. The low early detection rate of gastrointestinal tumors...

AI Technical Summary

Problems solved by technology

It improves the defect that the conventional insertion endoscope brings pain to the examinee, but it cannot avoid another defect of the insertion endoscope, that is, the inspection can only be based on the change of the surface morphology of the gastrointestinal tract, and it cannot be diagnosed. Tumors that do not cause obvious changes in the surface of the gastrointestinal tract, and it is difficult to find tumors in the folds and collapses of the gastrointestinal tract

At the same time, it also has the defect that the insertion endoscope does not exist. If it cannot cooperate with biopsy, the detection accuracy will be further reduced.

And limited by the size, the battery capacity is small, the working time is short, and it is impossible to conduct a complete diagnosis of the entire digestive tract

Images